{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:59:58Z","timestamp":1781312398196,"version":"3.54.1"},"reference-count":39,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>To analyse the long-term dynamics of the burden of sickness absenteeism (SA) at the societal and patient levels in employed patients with selected inflammatory rheumatic diseases (IRDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The burden of SA was analysed over 2 decades prior to the COVID-19 pandemic, with a focus on the subperiod following the introduction of the rheumatology clinical registry biorx.si. Population data for full-time employees on sick leave due to rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) were obtained from the national administrative database. The societal burden of SA was defined as the total annual number of calendar days on sick leave. The patient-level burden of SA was defined as the average annual number of days on sick leave per patient which was further disaggregated into the average annual number of sick leave episodes per patient and the average annual number of days per sick leave episode. The costs of SA were estimated using the human capital approach. An exponential trend method was used for analysis, and time series were tested for structural breaks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The societal burden of SA during the subperiod following the registry introduction decreased, on average, by 3.3% annually among RA patients. The average annual increase in the societal burden of SA was marginal for PsA patients (0.4%) and substantial for AS patients (8.7%). The societal and patient-level burdens of SA varied by sex and job sector. The patient-level burden of SA, however, decreased on average by 2.5% annually for RA patients and increased marginally for both PsA and AS patients. The key pattern suggesting potential improvements in the patient-level burden of SA for the analysed IRDs was an increase in the number of sick leave episodes per patient, offset by shorter episode duration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A study of the societal burden of SA, including its components, and the patient-level burden of SA can support the development of more effective strategies for managing SA and facilitating a faster return to work.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/sjph-2026-0015","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:32:55Z","timestamp":1780619575000},"page":"122-131","source":"Crossref","is-referenced-by-count":1,"title":["The Societal and Patient-Level Burden of Sickness Absenteeism in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Across Two Decades in Slovenia"],"prefix":"10.2478","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0057-6013","authenticated-orcid":false,"given":"Mitja","family":"Oblak","sequence":"first","affiliation":[{"name":"National Institute of Public Health , Trubarjeva cesta 2 , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-5473","authenticated-orcid":false,"given":"Ale\u0161a","family":"Lotri\u010d Dolinar","sequence":"additional","affiliation":[{"name":"University of Ljubljana , School of Economics and Business , Kardeljeva plo\u0161\u010dad 17 , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-9189","authenticated-orcid":false,"given":"\u017diga","family":"Rotar","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana , Department of Rheumatology , Vodnikova cesta 62 , Ljubljana , Slovenia"},{"name":"University of Ljubljana , Faculty of Medicine , Vrazov trg 2 , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4507-9010","authenticated-orcid":false,"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[{"name":"University Medical Centre Ljubljana , Department of Rheumatology , Vodnikova cesta 62 , Ljubljana , Slovenia"},{"name":"University of Ljubljana , Faculty of Medicine , Vrazov trg 2 , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0356-1204","authenticated-orcid":false,"given":"Petra","family":"Do\u0161enovi\u0107 Bon\u010da","sequence":"additional","affiliation":[{"name":"University of Ljubljana , School of Economics and Business , Kardeljeva plo\u0161\u010dad 17 , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026061300390990181_j_sjph-2026-0015_ref_001","doi-asserted-by":"crossref","unstructured":"Jacobs P, Bissonnette R, Guenther LC. Socioeconomic burden of immune-mediated inflammatory diseases \u2013 focusing on work productivity and disability. J Rheumatol. 2011;38 Suppl 88:55\u201361. doi: 10.3899\/jrheum.110901.","DOI":"10.3899\/jrheum.110901"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_002","doi-asserted-by":"crossref","unstructured":"Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229. doi: 10.1186\/ar2669.","DOI":"10.1186\/ar2669"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_003","doi-asserted-by":"crossref","unstructured":"Batko B, Rolska-W\u00f3jcik P, W\u0142adysiuk M. Indirect costs of rheumatoid arthritis depending on type of treatment-a systematic literature review. Int J Environ Res Public Health. 2019;16(16):2966. doi: 10.3390\/ijerph16162966.","DOI":"10.3390\/ijerph16162966"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_004","doi-asserted-by":"crossref","unstructured":"Kawalec P, Malinowski KP. The indirect costs of psoriatic arthritis: Systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15(1):125\u2013132. doi: 10.1586\/14737167.2015.965154.","DOI":"10.1586\/14737167.2015.965154"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_005","doi-asserted-by":"crossref","unstructured":"Malinowski KP, Kawalec P. The indirect costs of ankylosing spondylitis: A systematic review and meta-analysis. Expert Rev Pharmacoecon Outcomes Res. 2015;15(2):285\u2013300. doi: 10.1586\/14737167.2015.1001370.","DOI":"10.1586\/14737167.2015.1001370"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_006","doi-asserted-by":"crossref","unstructured":"Filipovic I, Walker D, Forster F, Curry AS. Quantifying the economic burden of productivity loss in rheumatoid arthritis. Rheumatology. 2011;50(6):1083\u20131090. doi: 10.1093\/rheumatology\/keq399.","DOI":"10.1093\/rheumatology\/keq399"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_007","doi-asserted-by":"crossref","unstructured":"Hsieh PH, Wu O, Geue C, McIntosh E, McInnes IB, Siebert S. Economic burden of rheumatoid arthritis: A systematic review of literature in biologic era. Ann Rheum Dis. 2020;79(6):771\u2013777. doi: 10.1136\/annrheumdis-2019-216243.","DOI":"10.1136\/annrheumdis-2019-216243"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_008","doi-asserted-by":"crossref","unstructured":"Yuasa A, Yonemoto N, Kamei K, Murofushi T, LoPresti M, Taneja A, et al. Systematic literature review of the use of productivity losses\/gains in cost-effectiveness analyses of immune-mediated disorders. Adv Ther. 2022;39(12):5327\u20135350. doi: 10.1007\/s12325-022-02321-z.","DOI":"10.1007\/s12325-022-02321-z"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_009","doi-asserted-by":"crossref","unstructured":"D\u2019Angiolella LS, Cortesi PA, Lafranconi A, Micale M, Mangano S, Cesana G, et al. Cost and cost effectiveness of treatments for psoriatic arthritis: A systematic literature review. Pharmacoeconomics. 2018;36(5):567\u2013589. doi: 10.1007\/s40273-018-0618-5.","DOI":"10.1007\/s40273-018-0618-5"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_010","doi-asserted-by":"crossref","unstructured":"Huscher D, Merkesdal S, Thiele K, Zeidler H, Schneider M, Zink A. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany. Ann Rheum Dis. 2006;65(9):1175\u20131183. doi: 10.1136\/ard.2005.046367.","DOI":"10.1136\/ard.2005.046367"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_011","doi-asserted-by":"crossref","unstructured":"Lenssinck MLB, Burdorf A, Boonen A, Gignac MA, Hazes JMW, Luime JJ. Consequences of inflammatory arthritis for workplace productivity loss and sick leave: A systematic review. Ann Rheum Dis. 2013;72(4):493\u2013505. doi: 10.1136\/annrheumdis-2012-201998.","DOI":"10.1136\/annrheumdis-2012-201998"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_012","doi-asserted-by":"crossref","unstructured":"Antczak E, Miszczy\u0144ska KM. Measuring and assessing sick absence from work: A European cross-sectional study. Comp Econ Res. 2023;26(4):187\u2013211. doi: 10.18778\/1508-2008.26.37.","DOI":"10.18778\/1508-2008.26.37"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_013","doi-asserted-by":"crossref","unstructured":"Ziegler S, Huscher D, Karberg K, Krause A, Wassenberg S, Zink A. Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997\u20132007: Results from the National Database of the German Collaborative Arthritis Centres. Ann Rheum Dis. 2010;69(10):1803\u20131808. doi: 10.1136\/ard.2009.122101.","DOI":"10.1136\/ard.2009.122101"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_014","doi-asserted-by":"crossref","unstructured":"Mau W, Thiele K, Lamprecht J. Trends of work force participation of patients with rheumatic diseases. Z Rheumatol. 2014;73(1):11\u201319. doi: 10.1007\/s00393-013-1205-y.","DOI":"10.1007\/s00393-013-1205-y"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_015","doi-asserted-by":"crossref","unstructured":"Huscher D, Mittendorf T, von Hin\u00fcber U, K\u00f6tter I, Hoese G, Pf\u00e4fflin A, et al. Evolution of cost structures in rheumatoid arthritis over the past decade. Ann Rheum Dis. 2015;74(4):738\u2013745. doi: 10.1136\/annrheumdis-2013-204311.","DOI":"10.1136\/annrheumdis-2013-204311"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_016","doi-asserted-by":"crossref","unstructured":"Huscher D, Thiele K, Rudwaleit M, Albrecht KC, Bischoff S, Krause A, et al. Trends in treatment and outcomes of ankylosing spondylitis in outpatient rheumatological care in Germany between 2000 and 2012. RMD Open. 2015;1(1):e000033. doi: 10.1136\/rmdopen-2014-000033.","DOI":"10.1136\/rmdopen-2014-000033"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_017","doi-asserted-by":"crossref","unstructured":"Stolwijk C, Castillo-Ortiz JD, Gignac M, Luime J, Boonen A. Importance of contextual factors when measuring work outcome in ankylosing spondylitis: A systematic review by the OMERACT worker productivity group. Arthritis Care Res. 2015;67(9):1316\u20131327. doi: 10.1002\/acr.22573.","DOI":"10.1002\/acr.22573"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_018","doi-asserted-by":"crossref","unstructured":"Nielsen C, Petersson IF, Jacobsson LTH, J\u00f6ud A. Secular trends in sickness absence among Swedish patients with ankylosing spondylitis and psoriatic arthritis. Rheumatol Int. 2018;38(2):275\u2013282. doi: 10.1007\/s00296-017-3809-z.","DOI":"10.1007\/s00296-017-3809-z"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_019","doi-asserted-by":"crossref","unstructured":"Westerlund H, Ferrie J, Hagberg J, Jeding K, Oxenstierna G, Theorell T. Workplace expansion, long-term sickness absence, and hospital admission. Lancet. 2004;363(9416):1193\u20131197. doi: 10.1016\/S0140-6736(04)15949-7.","DOI":"10.1016\/S0140-6736(04)15949-7"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_020","unstructured":"European Commission. State aid cases: Slovenia [internet]. 2025 [cited 2025 Jun 1]. Available at: https:\/\/commission.europa.eu\/strategy-and-policy\/coronavirus-response\/supporting-jobs-and-economy-during-coronavirus-pandemic\/state-aid-cases\/slovenia_en"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_021","doi-asserted-by":"crossref","unstructured":"Rotar \u017d, Tom\u0161i\u010d M, Praprotnik S. The persistence of golimumab compared to other tumour necrosis factor-\u03b1 inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs-BioR x.si. Clin Rheumatol. 2019;38(2):297\u2013305. doi: 10.1007\/s10067-018-4324-7.","DOI":"10.1007\/s10067-018-4324-7"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_022","doi-asserted-by":"crossref","unstructured":"Kvien TK, Balsa A, Betteridge N, Buch MH, Durez P, Favalli EG, et al. Considerations for improving quality of care of patients with rheumatoid arthritis and associated commorbidities. RMD Open. 2020;6(2):e001211. doi: 10.1136\/rmdopen-2020-001211.","DOI":"10.1136\/rmdopen-2020-001211"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_023","doi-asserted-by":"crossref","unstructured":"Nikiphorou E, Buch MH, Hyrich KL. Biologics registers in RA: Methodological aspects, current role and future applications. Nat Rev Rheumatol. 2017;13(8):503\u2013510. doi: 10.1038\/nrrheum.2017.81.","DOI":"10.1038\/nrrheum.2017.81"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_024","unstructured":"Nacionalni in\u0161titut za javno zdravje. Evidenca za\u010dasne \/ trajne odsotnosti z dela zaradi bolezni, po\u0161kodb, nege, spremstva in drugih vzrokov (NIJZ 3) [internet]. 2025 [cited 2025 Jun 1]. Available at: https:\/\/podatki.nijz.si\/docs\/1_07_Bolni\u0161ka_odsotnost.pdf"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_025","unstructured":"Eurostat. NACE Rev. 2 \u2013 Statistical classification of economic activities [internet]. 2025 [cited 2025 Jun 1]. Available at: https:\/\/ec.europa.eu\/eurostat\/web\/products-manuals-and-guidelines\/-\/ks-ra-07-015"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_026","unstructured":"Eurostat. Employment \u2013 annual statistics [internet]. 2025 [cited 2025 Jun 1]. Available at: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Employment_-_annual_statistics"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_027","unstructured":"Statisti\u010dni urad Republike Slovenije. Podatkovna baza SiStat [internet]. 2025 [cited 2025 Jun 1]. Available at: https:\/\/pxweb.stat.si\/SiStat\/sl\/Podrocja\/Index\/139\/delo-in-brezposelnost"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_028","unstructured":"Statisti\u010dni urad Republike Slovenije. Strukturna statistika pla\u010d. 2023 [cited 2026 Jan 2]. Available at: https:\/\/www.stat.si\/statweb\/File\/DocSysFile\/8153"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_029","doi-asserted-by":"crossref","unstructured":"Oblak M, Lotri\u010d Dolinar A, Rotar \u017d, Tom\u0161i\u010d M, Do\u0161enovi\u0107 Bon\u010da P. Research data for the article \u00bbThe societal and patient-level burden of sickness absenteeism in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis across two decades in Slovenia\u00ab [Internet]. Geneva: Zenodo; 2026. [cited 2026 Apr 13]. Available at: https:\/\/doi.org\/10.5281\/zenodo.19551939","DOI":"10.2478\/sjph-2026-0015"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_030","doi-asserted-by":"crossref","unstructured":"Mastekaasa A. Absenteeism in the public and the private sector: Does the public sector attract high absence employees? J Publ Adm Res Theor. 2020;30(1):60\u201376. doi: 10.1093\/jopart\/muz003.","DOI":"10.1093\/jopart\/muz003"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_031","doi-asserted-by":"crossref","unstructured":"Ehlert, A Garc\u00eda-Mor\u00e1n E. Workers\u2019 self-selection into public sector employment: A tale of absenteeism. Kyklos. 2022;75(3):394\u2013409. doi: 10.1111\/kykl.12300.","DOI":"10.1111\/kykl.12300"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_032","doi-asserted-by":"crossref","unstructured":"Alomari A, Alqudah Q, Maule G, Mestarihi A, Al-Omari S, Obeidat O, et al. Impact of seropositivity on mortality and extra-articular manifestations in rheumatoid arthritis: A nationwide propensity-matched cohort study. Mediterr J Rheumatol. 2025;36(4):616\u2013627. doi: 10.31138\/mjr.150425.smr.","DOI":"10.31138\/mjr.150425.smr"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_033","doi-asserted-by":"crossref","unstructured":"Passia E, Vis M, Coates LC, Soni A, Tchetverikov I, Gerards AH, et al. Sex-specific differences and how to handle them in early psoriatic arthritis. Arthritis Res Ther. 2022;24(1):22. doi: 10.1186\/s13075-021-02680-y.","DOI":"10.1186\/s13075-021-02680-y"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_034","doi-asserted-by":"crossref","unstructured":"Hansen SM, Hetland ML, Pedersen J, \u00d8stergaard M, Rubak TS, Bjorner JB. Work ability in rheumatoid arthritis patients: A register study on the prospective risk of exclusion and probability of returning to work. Rheumatology. 2017;56(7):1135\u20131143. doi: 10.1093\/rheumatology\/kex064.","DOI":"10.1093\/rheumatology\/kex064"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_035","doi-asserted-by":"crossref","unstructured":"ter Wee MM, Lems WF, Usan H,, Gulpen A, Boonen A. The effect of biological agents on work participation in rheumatoid arthritis patients: A systematic review. Ann Rheum Dis. 2012;71(2):161\u2013171. doi: 10.1136\/ard.2011.154583.","DOI":"10.1136\/ard.2011.154583"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_036","doi-asserted-by":"crossref","unstructured":"Park HS, del Campo PD, Plana MN, La Borda JPY, Guerra-Rodr\u00edguez M, Moreno M, et al. Efficacy of withdrawal or tapering of bDMARDs vs. standard regimen in axial spondyloarthritis patients: Systematic review and meta-analysis informing the update of the Spanish Society of Rheumatology Guideline. Front Med. 2025;12:1621313. doi: 10.3389\/fmed.2025.1621313.","DOI":"10.3389\/fmed.2025.1621313"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_037","doi-asserted-by":"crossref","unstructured":"Tang K, Escorpizo R, Beaton DE, Bombardier C, Lacaille D, Zhang W, et al. Measuring the impact of arthritis on worker productivity: Perspectives, methodologic issues, and contextual factors. J Rheumatol. 2011;38(8):1776\u20131790. doi: 10.3899\/jrheum.110405.","DOI":"10.3899\/jrheum.110405"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_038","doi-asserted-by":"crossref","unstructured":"Frieden TR. Evidence for health decision making \u2013 beyond randomized, controlled trials. N Engl J Med. 2017;377(5):465\u2013475. doi: 10.1056\/NEJMra1614394.","DOI":"10.1056\/NEJMra1614394"},{"key":"2026061300390990181_j_sjph-2026-0015_ref_039","doi-asserted-by":"crossref","unstructured":"Tillett W, Bojke L. Work disability and the cost-effectiveness of drugs to treat rheumatic diseases \u2013 time for a new dialogue? J Rheumatol. 2018;45(8):1075\u20131077. doi: 10.3899\/jrheum.180197.","DOI":"10.3899\/jrheum.180197"}],"container-title":["Slovenian Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/sjph-2026-0015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:39:39Z","timestamp":1781311179000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/sjph-2026-0015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,1]]},"published-print":{"date-parts":[[2026,6,1]]}},"alternative-id":["10.2478\/sjph-2026-0015"],"URL":"https:\/\/doi.org\/10.2478\/sjph-2026-0015","relation":{},"ISSN":["1854-2476"],"issn-type":[{"value":"1854-2476","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]}}}